These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. Song GA; Kim HJ; Woo KM; Baek JH; Kim GS; Choi JY; Ryoo HM J Biol Chem; 2010 Jul; 285(29):22542-53. PubMed ID: 20463014 [TBL] [Abstract][Full Text] [Related]
28. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. Chakkalakal SA; Shore EM Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138 [TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. Schoenmaker T; Zwaak J; Loos BG; Volckmann R; Koster J; Eekhoff EMW; de Vries TJ Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047804 [TBL] [Abstract][Full Text] [Related]
30. The Fibrodysplasia Ossificans Progressiva (FOP) mutation p.R206H in ACVR1 confers an altered ligand response. Hildebrand L; Stange K; Deichsel A; Gossen M; Seemann P Cell Signal; 2017 Jan; 29():23-30. PubMed ID: 27713089 [TBL] [Abstract][Full Text] [Related]
31. Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva. Cai J; Orlova VV; Cai X; Eekhoff EMW; Zhang K; Pei D; Pan G; Mummery CL; Ten Dijke P Stem Cell Reports; 2015 Dec; 5(6):963-970. PubMed ID: 26626181 [TBL] [Abstract][Full Text] [Related]
32. High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva. Cappato S; Tonachini L; Giacopelli F; Tirone M; Galietta LJ; Sormani M; Giovenzana A; Spinelli AE; Canciani B; Brunelli S; Ravazzolo R; Bocciardi R Dis Model Mech; 2016 Jun; 9(6):685-96. PubMed ID: 27125279 [TBL] [Abstract][Full Text] [Related]
33. The serum levels of activin A and bone morphogenetic protein-4 and -6 in patients with fibrodysplasia ossificans progressiva. Ye Z; Wang S; Shan C; Zhu Q; Xue Y; Zhang K Orphanet J Rare Dis; 2023 May; 18(1):111. PubMed ID: 37165433 [TBL] [Abstract][Full Text] [Related]
34. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369 [TBL] [Abstract][Full Text] [Related]
35. iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. Gao P; Inada Y; Hotta A; Sakurai H; Ikeya M Stem Cell Res Ther; 2024 Mar; 15(1):83. PubMed ID: 38500216 [TBL] [Abstract][Full Text] [Related]